Evidence ‐based pharmacotherapies used in the postdischarge phase are associated with improved one‐year survival in senior patients hospitalized with heart failure

ConclusionsIn a cohort of senior patients hospitalized with HF, dispensing of a RASI or β‐blocker within 60 days postdischarge is associated with a 1‐year survival benefit. Early postdischarge support programs after recent HF hospitalization should include measures to optimize adherence to evidence‐based medications.

Source: Cardiovascular Therapeutics - January 28, 2019 Category: Cardiology Authors: Xiwen Qin, Joseph Hung, Matthew Knuiman, Tiew ‐Hwa K. Teng, Tom Briffa, Frank M. Sanfilippo Tags: ORIGINAL RESEARCH ARTICLE Source Type: research